VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxif... (ng statements contained in this press re...)

HOME >> MEDICINE >> TECHNOLOGY

VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy

Date:3/10/2008

ng statements contained in this press release as a result of new information, future events or otherwise.

About Novartis

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatological, gastrointestinal and respiratory areas. The company's mission is to improve people's lives by pioneering novel healthcare solutions.

Located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG (NYSE: NVS), a world leader in offering medicines to protect health, cure disease and improve well-being. Our goal is to discover, develop and successfully market innovative products to treat patients, ease suffering and enhance the quality of life. We are strengthening our medicine-based portfolio, which is focused on strategic growth platforms in innovation-driven pharmaceuticals, high-quality and low-cost generics, human vaccines and leading self-medication OTC brands. Novartis is the only company with leadership positions in these areas. In 2006, the Group's businesses achieved net sales of USD 37.0 billion and net income of USD 7.2 billion. Approximately USD 5.4 billion was invested in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 100,000 associates and operate in over 140 countries around the world. For more information, please visit http://www.pharma.us.novartis.com.
Additional press information available at htt
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
2. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
3. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
4. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Video: New Research Discovers Independent Brain Networks Control Human Walking
7. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
8. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
9. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
10. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
11. GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years

Post Your Comments:

(Date:12/6/2009)... Dec. 6 RNL Bio Co., Ltd, ... in adult stem cell therapeutics announced today that ... improved tremendously after receiving stem cell treatment. Park ... disease that affects the central nervous system (brain ... a disease in which the nerves of the ...

(Date:12/4/2009)... 4 A simple, inexpensive computer tool that measures ... the lungs picked up by a CT scanner can ... enable doctors to diagnose true cancers with fewer, less ... ) ,, The new diagnostic guidelines are described in ...

(Date:12/4/2009)... Thermographic Diagnostic Imaging (TDI), part of a ... continues to provide superior quality infrared imaging of ... sinus regions to assist in the early diagnosis ... Thermography utilizes infrared imaging cameras that "read" the ...

Breaking Medicine Technology:Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment 2 European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2 Discover Health Through Awareness 2 Discover Health Through Awareness 3 Cervarix Proves Effective Against HPV for Over 6 Years 62517 1 Cervarix Proves Effective Against HPV for Over 6 Years 62517 2 Breast Feeding Can Help Moms Heart Decades Later 62514 1 Breast Feeding Can Help Moms Heart Decades Later 62514 2 Breast Feeding Can Help Moms Heart Decades Later 62514 3 Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 6711 1 Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 6711 2 Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 6711 3

[0] Multiple Sclerosis Patient Finds Hope Through Stem Cell Treatment [0] European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis [0] Discover Health Through Awareness

... Mass., and WASHINGTON, Oct. 22 Boston,Scientific Corporation ... the SPIRIT,III Clinical Trial, which continue to support ... Express2(TM) Paclitaxel-Eluting,Coronary Stent System and add to the ... V (PROMUS(TM)) Everolimus Eluting Coronary,Stent System. An analysis ...

... Patient enrollment is complete in,the first randomized, ... outcomes and cost-effectiveness of a physiologic-guided,percutaneous coronary ... patients with multivessel coronary artery disease (CAD). ... update today at the Transcatheter,Cardiovascular Therapeutics symposium ...

Other Medicine Technology:Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 2 Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 3 Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures 4 Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease 2

Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures Patient Enrollment Complete in First Trial to Compare Physiologic Guidance vs. Angiographic Guidance of Stent Deployment in Patients with Multivessel Disease

(Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...

(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...

(Date:12/5/2009)... and myeloproliferative disorders are serious and often deadly ... Annual Meeting of the American Society of Hematology ... methods for patients suffering from acute promyelocytic leukemia, ... myelofibrosis that are based on a better understanding ...

(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor ... the knot, since research has shown that never-married adults have ... something wrong with those who go it alone anyway? , ... measures shows that never-married people aged 40 and up can ...

(Date:12/5/2009)... announced the launch of International Solutions, an innovative new international private ... UK equivalent. In addition to offering customers the flexibility to add ... and budgets, International Solutions enables customers to tailor their benefits to ... , ...

Breaking Medicine News(10 mins):Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7 Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8 Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2 Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8 Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9 Health News:Never Married, Over 40, Well-Adjusted 2 Health News:Never Married, Over 40, Well-Adjusted 3 Health News:AVIVA's Private Health Insurance Products Solutions Go International 2

[0] New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer [0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha [0] Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders [0] Never Married, Over 40, Well-Adjusted [0] AVIVA's Private Health Insurance Products Solutions Go International

... Increase In Revenues - - Florida Upholds Contract Award To Orchid Cellmark ... Paternity ... - Regional Tender Work Underway In U.K. -, PRINCETON, N.J., July ... DNA testing,services, today reported its financial results for the second quarter of,2008., Total ...

... Offers Cost-Effective, Turnkey Digital Marketing for ... Targeted Lead Generation, ... now can market themselves directly to,America,s 31 million back pain sufferers ... LLC. The portal, http://www.backcarenetwork.com, harnesses the power of the internet ...

... Cardiva Medical, Inc., a,privately held medical device company, announced ... the BMO Capital Markets 2008 Focus on,Healthcare conference on ... Broadway Hotel in New York City. Mr. Lien,s presentation ... growth,strategy., Details of the presentation follow: ...

... that allows physicians and dentists to request disability insurance quotes, ... ... San Clemente, CA (PRWEB) July 31, ... __title__ disability insurance] and life insurance brokerage service, recently launched ...

... in Brookhaven, Miss., is slated to receive a $500,000 ... and Human Services, and Education spending bill that was ... KDMC,s grant application, championed in part by U.S. Senator ... strategic service partner Strategic Health Care. Once awarded, the ...

... Easton Honda is hosting a blood drive at its Phillipsburg location ... ... Phillipsburg, NJ (PRWEB) July 31, 2008 -- Phillipsburg Easton Honda ... August 9th from 11:00AM to 1:45PM., , , , ,"Demand for ...

Orchid Cellmark Reports Second Quarter 2008 Financial Results New Website Portal Delivers Pre-Qualified Spinal Decompression Patients to Participating Doctors Cardiva Medical Announces Presentation at BMO Capital Markets 2008 Focus on Healthcare Conference New Website Helps Doctors and Dentists Locate Disability Insurance Healthcare Consulting Leader QHR, Strategic Health Care, Sen. Roger Wicker Partnership Yields $500,000 Grant for King's Daughters Medical Center Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive

... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...

The Freedom Clear catheter is a 100% latex-free, self-adhering, one piece catheter with an ultra-thin sheath for every day wear....

... Natural® all-silicone non-adhesive male external catheter ... of latex-related allergic reactions. It is ... to change external catheters several times ... Natural catheter comes with an adjustable ...

Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....

Medicine Products:

Personal Catheter-Male Freedom Clear® External Catheters Natural Male External Catheters Mitty-Pollack Needle Set - EchoTip®

VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxif...(ng statements contained in this press re...),Health